iv rtpa

In this review, we analyze the evidence—most of which is derived from observational research—supporting or contradicting current contraindications for administering IV rtPA to acute ischemic stroke patients. neurosanbe injeksi iv atau im Intravenous recombinant tissue plasminogen activator (rtPA) for acute ischemic stroke is drastically underused. sop injeksi im iv sc ic